Luo H - Search Results

1

Porphyrin-Based Metal-Organic Framework Compounds as Promising Nanomedicines in Photodynamic Therapy.

Yu W, Zhen W, Zhang Q, Li Y, Luo H, He J, Liu Y. Yu W, et al. Among authors: luo h. ChemMedChem. 2020 Oct 5;15(19):1766-1775. doi: 10.1002/cmdc.202000353. Epub 2020 Aug 31. ChemMedChem. 2020. PMID: 32715651 Review.

2

Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response.

Luo H, He J, Qin L, Chen Y, Chen L, Li R, Zeng Y, Zhu C, You X, Wu Y. Luo H, et al. Clin Exp Immunol. 2021 Jan;203(1):66-79. doi: 10.1111/cei.13510. Epub 2020 Sep 29. Clin Exp Immunol. 2021. PMID: 32894580 Free PMC article.

3

Isoliensinine: A Natural Compound with "Drug-Like" Potential.

Cheng Y, Li HL, Zhou ZW, Long HZ, Luo HY, Wen DD, Cheng L, Gao LC. Cheng Y, et al. Front Pharmacol. 2021 Apr 22;12:630385. doi: 10.3389/fphar.2021.630385. eCollection 2021. Front Pharmacol. 2021. PMID: 33967765 Free PMC article. Review.

4

From Microbiome to Inflammation: The Key Drivers of Cervical Cancer.

Zhou ZW, Long HZ, Cheng Y, Luo HY, Wen DD, Gao LC. Zhou ZW, et al. Front Microbiol. 2021 Nov 15;12:767931. doi: 10.3389/fmicb.2021.767931. eCollection 2021. Front Microbiol. 2021. PMID: 34867901 Free PMC article. Review.

5

System X_c ^-/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy.

Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Li FJ, et al. Front Pharmacol. 2022 Aug 29;13:910292. doi: 10.3389/fphar.2022.910292. eCollection 2022. Front Pharmacol. 2022. PMID: 36105219 Free PMC article. Review.

6

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.

Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. Long HZ, et al. Front Pharmacol. 2021 Apr 15;12:648636. doi: 10.3389/fphar.2021.648636. eCollection 2021. Front Pharmacol. 2021. PMID: 33935751 Free PMC article. Review.

7

Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways.

Zhou ZW, Long HZ, Xu SG, Li FJ, Cheng Y, Luo HY, Gao LC. Zhou ZW, et al. Front Pharmacol. 2022 May 13;13:899208. doi: 10.3389/fphar.2022.899208. eCollection 2022. Front Pharmacol. 2022. PMID: 35645817 Free PMC article. Review.

8

The Role of Microglia in Alzheimer's Disease From the Perspective of Immune Inflammation and Iron Metabolism.

Long HZ, Zhou ZW, Cheng Y, Luo HY, Li FJ, Xu SG, Gao LC. Long HZ, et al. Front Aging Neurosci. 2022 Jun 30;14:888989. doi: 10.3389/fnagi.2022.888989. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35847685 Free PMC article. Review.

9

Relationship between miRNA and ferroptosis in tumors.

Dai SM, Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, Gao LC. Dai SM, et al. Front Pharmacol. 2022 Nov 4;13:977062. doi: 10.3389/fphar.2022.977062. eCollection 2022. Front Pharmacol. 2022. PMID: 36408273 Free PMC article. Review.

10

Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.

Luo HY, Gao LC, Long HZ, Zhou ZW, Xu SG, Li FJ, Li HL, Cheng Y, Li CX, Peng XY, Li L, Chen R, Deng P. Luo HY, et al. Eur J Clin Pharmacol. 2023 May;79(5):663-670. doi: 10.1007/s00228-023-03484-6. Epub 2023 Mar 28. Eur J Clin Pharmacol. 2023. PMID: 36976322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,261 results

Search Page